Sanofi SA (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 207   

Articles published

SNY 53.17 -0.22 (-0.41%)
price chart
Investor's Alert � Insulet Corporation (NASDAQ:PODD), Hospira, Inc. (NYSE ...
Sanofi SA (ADR) (NYSE:SNY) posted that the U.S. FDA has enlarged the permitted age indication of Adacel (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed; Tdap) for active booster immunization for the prevention of ...
Related articles »  
Hot Stocks Today: AMD, AZN, HAL, and More
Astrom Biosciences Inc. (Nasdaq: ASTM) shares soared 35% to $4.95 in morning trading after announcing an agreement to acquire Sanofi SA's (NYSE ADR: SNY) Cell Therapy and Regenerative Medicine unit (CTRM) for $6.5 million. With the CTRM ...
Related articles »  
Large Cap Unusual Volume: TD Ameritrade Holding (NYSE:AMTD), Anadarko ...
Sanofi SA (ADR) (NYSE:SNY) is so confident that it has already spent EUR 300 million at a facility near Lyon, France and has started producing the drug since July 2013, and is ready to sell from late 2015 subject to regulatory approval.
Stocks Rallied on News- Sanofi (NYSE:SNY), Potash Corp./Saskatchewan ...
Genzyme, a Sanofi SA (ADR) (SNY), declared that after constructive discussions with the FDA the firm aims to resubmit in the Q2 its supplemental Biologics License Application seeking authorization of Lemtrada for the treatment of relapsing forms of ...
Related articles »  
Notable Movers: Incyte Corporation (NASDAQ:INCY), Mylan Inc (NASDAQ:MYL ...
Las Vegas, NV - April 7, 2014 - (TechSonian) - Incyte Corporation (NASDAQ:INCY) reported that a pivotal Phase III trial of ruxolitinib compared to best obtainable therapy in patients with polycythemia vera who are resistant to or intolerant of ...
Related articles »  
Healthcare Unusual volume: IsoRay (NYSEMKT:ISR), CytRx Corporation ...
Sanofi (ADR) (NYSE:SNY) Announces FDA Has Expanded Age Indication of Adacel� Tdap Vaccine to Include Persons 10 Years of Age. Sanofi SA (ADR) (NYSE:SNY) weekly performance is 0.56%. On last trading day company shares ended up $52.04.
Related articles »  
Amgen Takes Lead In Cholesterol Drug Race
Regeneron, which is partnered with Sanofi SA (ADR) (SNY), plans to conduct 12 studies on its drug in the category while Pfizer is working on understanding the long term benefits of its drug with a program comprising 22,000 patients.
Related articles »  
Versatile News at Street: Zimmer Holdings (NYSE:ZMH), Sanofi (NYSE:SNY), Eli ...
Sanofi SA (ADR) (NYSE:SNY) [Trend Analysis] dropped -0.84%, closing the day at $51.84 in last regular trading while in after hours trading shares moved up 0.10%.
News In Focus: Sanofi (NYSE:SNY), UTi Worldwide (NASDAQ:UTIW), North ...
Sanofi SA (ADR) (NYSE:SNY) [Trend Analysis] reported the gain of +0.58% and closed at $52.98 with the total average volume of 1.30 million shares.
Related articles »  
Uptrend Stocks: HSBC Holdings (NYSE:HSBC), Intel (NASDAQ:INTC), Netflix ...
Genzyme, a Sanofi SA's (ADR) (SNY) company, earlier reported that the FDA permitted revised prescribing information for the use of Thyrogen (thyrotropin alfa for injection) to widen the dose range of radioiodine at what time used for thyroid remnant ...
Related articles »